Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,860.00
  • Today's Change-8.00 / -0.43%
  • Shares traded829.71k
  • 1 Year change-28.19%
  • Beta0.3133
Data delayed at least 20 minutes, as of May 14 2024 16:35 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
ASSETS
Cash And Short Term Investments363946
Total Receivables, Net128125102
Total Inventory858477
Prepaid expenses7.708.506.60
Other current assets, total1.501.200.30
Total current assets259258232
Property, plant & equipment, net483505403
Goodwill, net108111102
Intangibles, net667256
Long term investments625149
Note receivable - long term8.208.601.80
Other long term assets4.902.200
Total assets1,0081,018851
LIABILITIES
Accounts payable353624
Accrued expenses7.709.008.20
Notes payable/short-term debt000
Current portion long-term debt/capital leases141723
Other current liabilities, total918988
Total current liabilities147151143
Total long term debt218207129
Total debt232224152
Deferred income tax516053
Minority interest(7.7)(6.4)(1.5)
Other liabilities, total242830
Total liabilities433439353
SHAREHOLDERS EQUITY
Common stock6.606.606.60
Additional paid-in capital179179179
Retained earnings (accumulated deficit)361341320
Treasury stock - common(0.1)(0.1)(0.1)
Unrealized gain (loss)------
Other equity, total2952(7.9)
Total equity575579498
Total liabilities & shareholders' equity1,0081,018851
Total common shares outstanding666666
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.